Chronic Bronchitis Clinical Trial
Official title:
A Feasibility Study: A Safety Evaluation of RheOx on Patients With Chronic Bronchitis in the United States
An early feasibility study (EFS) to assess the safety and clinical utility of RheOx on patients with chronic bronchitis in the United States.
RheOx is a device-based, energy delivery system that delivers energy for the ablation of soft tissue such as the airway epithelium and sub-mucosal tissue layers. The energy is delivered via a proprietary catheter through the bronchoscope. Two sessions of treatment will be delivered one month apart. The right lung is treated at the first treatment session and the left lung is treated at the second treatment session (approximately one month after the right side is treated). Treatment will be delivered by a respiratory physician (interventional pulmonologist) in a tertiary teaching hospital during a bronchoscopic procedure. The bronchoscopy will be delivered during general anesthesia. It is anticipated that the bronchoscopic procedure will last less than 60 minutes in total. Treatment will be deemed to have been delivered following the successful treatment during the two bronchoscopies. Subjects will be required to submit tests during the study including three CT scans (lung), respiratory function tests, exercise testing. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT05533931 -
Resistive Breathing Versus Inspiratory Hold Technique in Patients With Chronic Bronchitis
|
N/A | |
| Completed |
NCT01420445 -
Safety/Tolerability and Efficacy of YHD001 in Patients With Acute and Chronic Bronchitis
|
Phase 2 | |
| Completed |
NCT01071161 -
The Effect of Azithromycin in Patients With Chronic Obstructive Pulmonary Disease (COPD) and Chronic Productive Cough
|
Phase 3 | |
| Terminated |
NCT00524095 -
Bronchiectasis in Chronic Obstructive Pulmonary Disease (COPD) Patients: Role of Prophylaxis
|
Phase 2 | |
| Completed |
NCT00903955 -
Mucus Dehydration and Evolution of Chronic Obstructive Pulmonary Disease (COPD) Lung Disease
|
N/A | |
| Completed |
NCT00129883 -
Adherence to Guidelines for Antibiotic Use in Respiratory Infections at Hospitals
|
N/A | |
| Recruiting |
NCT05075083 -
Immunogenicity and Safety of an Inactivated COVID-19 Vaccine in Elderly People With Chronic Bronchitis and COPD
|
Phase 4 | |
| Recruiting |
NCT05075057 -
Immunogenicity and Safety of an Inactivated COVID-19 Vaccine in Patients Aged ≥60 Years With Chronic Bronchitis and COPD
|
Phase 4 | |
| Terminated |
NCT02838108 -
The Relationship Between GOLD Risk Group and Clinical Outcomes in a Community-based COPD Cohort
|
||
| Completed |
NCT02128529 -
Epidemiology of Chronic Bronchitis in Patients With Chronic Obstructive Pulmonary Disease (COPD)
|
N/A | |
| Withdrawn |
NCT00298402 -
Macrophages in Smokers' Lung
|
N/A | |
| Completed |
NCT00298389 -
Macrophage Phagocytosis in COPD
|
||
| Terminated |
NCT00132951 -
KEYS: Study Comparing Clinical Health Outcomes of Telithromycin Versus Azithromycin in Outpatients With Community-acquired Lower Respiratory Tract Infections
|
Phase 4 | |
| Active, not recruiting |
NCT01969344 -
Study of COPD Subgroups and Biomarkers
|
||
| Completed |
NCT00680056 -
Add-on Effects of Tiotropium Over Formoterol in Exercise Tolerance on Chronic Obstructive Pulmonary Disease Patients
|
Phase 4 | |
| Completed |
NCT00106080 -
Improving the Quality of End-of-Life Communication for Patients With Chronic Obstructive Pulmonary Disease (COPD)
|
N/A | |
| Completed |
NCT00042718 -
A Study of the Effectiveness and Safety of High Dose, Short-course Levofloxacin in the Treatment of Acute Bacterial Exacerbation (Worsening) of Chronic Bronchitis.
|
Phase 3 | |
| Completed |
NCT02099799 -
The Effect of Physical Activity Promotion on Short and Long-term Outcomes in COPD
|
N/A | |
| Completed |
NCT00342030 -
Dietary and Genetic Factors in Asthma & Chronic Bronchitis in a Cohort of Chinese Singaporeans
|
N/A | |
| Withdrawn |
NCT02341183 -
Novel Therapies for Muco-Obstructive Lung Diseases: Testing the Transnasal Pulmonary Delivery Device in COPD/CB Subjects
|
N/A |